Introduction {#s1}
============

Pneumonia is a common complication in patients with stroke.[@R1] It occurs in about 9% of patients with stroke, and 28% of patients with stroke in the intensive care unit.[@R2] A variety of factors, such as older age, dysphagia and higher stroke severity score, which are assessed by the National Institutes of Health Stroke Scale (NIHSS), are associated with stroke-associated pneumonia (SAP).[@R3] SAP potentially increases the risk of a poor and fatal outcome,[@R4] and increases the economic burden on patients with stroke.[@R5] Although a preventive antibiotic cannot improve the prognosis of patients with stroke, it is proved to be effective to decrease the incidence of SAP.[@R6] Oral care is also proved to be effective to reduce the incidence of SAP.[@R3] Recognising patients with stroke at high risk of pneumonia and providing preventive intervention can be helpful to reduce the incidence of SAP.

Several risk scoring models were reported to improve the recognition of the high risk of pneumonia in patients with stroke, including Kwon\'s score,[@R7] the PANTHER-IS score,[@R8] Chumbler\'s score,[@R9] A^2^DS^2^[@R10] and AISAPS.[@R11] There are many advantages to the wide use of these risk models, such as assisting clinicians to identify patients with stroke with high risk of pneumonia and facilitating the selection of patients in clinic trials. However, these models have not been applied extensively to patients in different cohorts from various races and areas. They need to be externally validated before they can be used in clinical practice.

We conducted this study to determine whether these risk models could effectively predict SAP during hospitalisation in Chinese patients with IS. Since the risk scores of ischaemic stroke-associated pneumonia (like A^2^DS^2^ and AISAPS) are different from that of haemorrhagic stroke (like intracerebral haemorrhage-associated pneumonia score (ICH-APSs)),[@R12] we only focused on patients with ischaemic stroke to control potential confounders.

Methods {#s2}
=======

Study population {#s2a}
----------------

We identified all consecutive patients with IS in West China hospital between January 2011 and September 2013. Inclusion criteria: aged≥18; patients with IS who were admitted to hospital within 30 days of onset; ischaemic stroke was diagnosed based on the WHO criteria; IS was confirmed by brain CT or MRI. Exclusion criteria: patients with transient ischaemic attack (TIA); pneumonia happened before admission. Severity of stroke was assessed by NIHSS.[@R13] Consciousness was evaluated by Glasgow Coma Scale.[@R14] The subtype of IS was classified based on the Oxfordshire Community Stroke Project criteria: partial anterior circulation infarct, total anterior circulation infarct, lacunar infarction and posterior circulation infarct.[@R15] Dysphagia was evaluated by a neurological clinician with the water drinking test. Prestroke dependence was defined as modified Rankin Scale ≥3.

Outcome measures {#s2b}
----------------

The primary outcome was the presence of SAP in hospitalised patients with IS. SAP was diagnosed by the treating physician according to the modified criteria of US Centers for Disease Control and Prevention criteria for hospital-acquired pneumonia. Pneumonia was diagnosed when at least one of the first and one of the latter criteria were fulfilled: (A) abnormal respiratory examination, pulmonary infiltrates in chest X-rays; (B) productive cough with purulent sputum, microbiological cultures from the lower respiratory tract or blood cultures, leucocytosis and elevation of C reactive protein.[@R16]

Risk prediction scores of SAP {#s2c}
-----------------------------

We indentified five risk scoring models of SAP in total. Kwon\'s score was derived from 286 patients with stroke in a single hospital, as was the PANTHER-IS score (derived from 223 patients with IS). Chumbler *et al* developed their risk model from 925 patients in multicentre hospitals. A^2^DS^2^ was derived from 15 335 patients in multicentre communities and hospitals, as was AISAPS (derived from 8820). We excluded Kwon\'s score because it involved the variable (mechanical ventilation) which we thought would be a medical intervention rather than the original character of the patient. We excluded the PANTHER-IS score because it focused on patients with IS in the middle cerebral artery territory in the neurological intensive care unit, which would be not suitable to common patients with stroke.

Statistical analysis {#s2d}
--------------------

Given the non-normal distribution of data, median values with 25th and 75th centiles were calculated for continuous variables and comparisons between groups were performed using the Nonparametric test. Categorical variables were described as counts and percentages, while comparisons between two groups were made with the χ^2^ test.

The model fit was measured with the Hosmer-Lemeshow goodness-of-fit statistic. The discriminatory ability of each risk model was evaluated using the area under the receiver operating characteristic curve (c statistic). The c statistic for each pair of scores was compared with the DeLong method.

We considered a p value \<0.05 (2-tailed) to be statistically significant. All analyses were performed using MedCalc.

Results {#s3}
=======

Between January 2011 and September 2013, 1814 patients with IS were consecutively referred to the hospital. Of them, 140 patients were with TIA, 2 patients younger than 18 years, 104 patients with stroke onset more than 1 month or with pneumonia prior to admission. A total of 1569 patients were finally included in the present study. The median age was 65 years (IQR, 25--75), and 60% were male. Among all participants, 240 (15.3%) patients acquired pneumonia during hospitalisation ([table 1](#SVN2016000025TB1){ref-type="table"}).

###### 

Baseline characteristics of patients with and without stroke-associated pneumonia

                                                Pneumonia group      Non-pneumonia group   p Value
  --------------------------------------------- -------------------- --------------------- -----------
  Age, median (IQR), year                       70.0 (61.0, 78.0)    64.0 (53.0, 73.0)     \<0.001\*
  Sex                                                                                      0.205
   Male, n, %                                   134 (55.8)           800 (60.2)            
   Female, n, %                                 106 (44.2)           529 (39.8)            
  Hypertension, n, %                            141 (58.8)           764 (57.5)            0.715
  Diabetes mellitus, n, %                       71 (29.6)            371 (27.9)            0.597
  Hyperlipaemia, n, %                           16 (38.1)            142 (10.7)            0.057
  History of stroke or TIA, n, %                42 (17.5)            169 (12.7)            0.046\*
  Valvular heart disease, n, %                  2 (0.8)              7 (0.5)               0.563
  Coronary heart disease, n,%                   24 (10.0)            58 (4.4)              \<0.001\*
  Atrial fibrillation, n, %                     72 (30.0)            109 (8.2)             \<0.001\*
  Congestive heart failure, n, %                3 (1.3)              1 (\<0.1)             \<0.001\*
  COPD, n, %                                    15 (6.3)             16 (1.2)              \<0.001\*
  History of pneumonia, n,%                     17 (7.1)             50 (3.8)              0.019\*
  Current smoking, n, %                         33 (13.8)            148 (11.1)            0.243
  Excess alcohol consumption, n, %              25 (10.4)            156 (11.7)            0.555
  Found down at onset, n, %                     42 (17.5)            80 (6.0)              \<0.001\*
  Dyaphasia, n, %                               130 (9.8)            272 (20.5)            \<0.001\*
  NIHSS, median (IQR) score                     9.5 (5, 14.0)        3.0 (1.0, 7.0)        \<0.001\*
  GCS, median (IQR) score                       14.0 (11.0, 15.0)    15.0 (14.0,15.0)      \<0.001\*
  OCSP                                                                                     \<0.001\*
   Lacunar infarction, n, %                     7 (2.9)              66 (4.9)              
   Total anterior circulation infarct, n, %     39 (16.3)            61 (4.6)              
   Partial anterior circulation infarct, n, %   165 (68.8)           939 (70.7)            
   Posterior circulation infarct, n, %          29 (12.1)            263 (19.8)            
  Glu, median (IQR) mmol/L                      6.73 (5.20, 8.60)    5.64 (4.87, 7.13)     \<0.001\*
  WCC, median (IQR) 10^12^/L                    8.34 (6.55, 10.71)   6.69 (5.44, 8.22)     \<0.001\*

\*p\<0.05.

COPD, chronic obstructive pulmonary disease; GCS, Glasgow Coma Scale; NIHSS, National Institutes of Health Stroke Scale; OCSP, Oxfordshire Community Stroke Project; TIA, transient ischaemic attack; WCC, white cell count.

[Table 2](#SVN2016000025TB2){ref-type="table"} demonstrated the items of each risk scoring model included in the study. The abilities of these three risk models of predicting pneumonia are summarised in [table 3](#SVN2016000025TB3){ref-type="table"}. The discriminatory abilities of all models were described as the area under the receiver operating characteristic curve (AUROC), which is shown in [figure 1](#SVN2016000025F1){ref-type="fig"}. The AUROC of all models was 0.659 (p \<0.001, Chumbler\'s score), 0.728 (p \<0.001, A^2^DS^2^) and 0.758 (p\<0.001, AISAPS), respectively. The differences in AUROC (ΔAUROC) between any two risk models were significant (p\<0.05). The calibrations of all models assessed by the Hosmer-Lemeshow test were not significant (p\>0.05). Although the incidence of SAP was underpredicted by all of these risk models, the predicted incidence of AISAPS was closer to the observed incidence ([table 4](#SVN2016000025TB4){ref-type="table"}).

###### 

The content of each risk model

  Number   Chumbler\'s score (5 items)   A^2^DS^2^ (5 items)   AISASP (11 items)
  -------- ----------------------------- --------------------- --------------------------
  1        age                           age                   age
  2        dysphagia                     dysphagia             dysphagia
  3        NIHSS                         NIHSS                 NIHSS
  4        found down at onset           atrial fibrillation   atrial fibrillation
  5        history of pneumonia          male                  GCS
  6        --                            --                    congestive heart failure
  7        --                            --                    COPD
  8        --                            --                    current smoker
  9        --                            --                    prestroke dependence
  10       --                            --                    OCSP subtype
  11       --                            --                    admission glucose

COPD, chronic obstructive pulmonary disease; GCS, Glasgow Coma Scale; OCSP, Oxfordshire Community Stroke Project; NIHSS, National Institutes of Health Stroke Scale.

###### 

Comparison of various risk models for stroke-associated pneumonia

  Risk models         OR       p Value    Hosmer-Lemeshow test   AUROC   p Value
  ------------------- -------- ---------- ---------------------- ------- ---------
  Chumbler\'s score   1.8138   \<0.0001   p=0.6243               0.659   \<0.001
  A^2^DS^2^           1.4248   \<0.0001   p=0.0953               0.728   \<0.001
  AISAPS              1.2365   \<0.0001   p=0.8927               0.758   \<0.001

AUROC,area under the receiver operating characteristic curve.

###### 

Observed and predicted rate of stroke-associated pneumonia

                      Incidence of SAP (%)
  ------------------- ----------------------
  Observed            15.3
  Predicted by        
  Chumbler\'s score   10.7
   A^2^DS^2^          10.8
   AISAPS             11.7

SAP,stroke-associated pneumonia.

![The AUROC of each risk model. (A). The AUROC of Chumbler\'s score; (B). The AUROC of A^2^DS^2^; (C). The AUROC of AISAPS; (D). The comparison of AUROC of three risk models. AUROC, area under the receiver operating characteristic curve.](svn-2016-000025f01){#SVN2016000025F1}

The optimal cut-off value of risk models for SAP is displayed in [table 5](#SVN2016000025TB5){ref-type="table"}. The optimal cut-off value was 1 for Chumbler\'s score, whose sensitivity was 71.49%, specificity was 52.93%, positive predictive value (PPV) was 21.66% and negative predictive value (NPV) was 91.07%. The optimal cut-off value was 3 for A^2^DS^2^, whose sensitivity was 69.83%, specificity was 65.56%, PPV was 26.96% and NPV was 92.27%. The optimal cut-off value was 6 for AISAPS, whose sensitivity was 76.45%, specificity was 62.56%, PPV was 27.19% and NPV was 93.59%.

###### 

Optimal cut-off value of risk models for stroke-associated pneumonia

                      Y-index   Cut-off point   Sensitivity (%)   Specificity (%)   PPV     NPV (%)
  ------------------- --------- --------------- ----------------- ----------------- ------- ---------
  Chumbler\'s score   0.2442    1               71.49             52.93             21.66   91.07
  A^2^DS^2^           0.3540    3               69.83             65.56             26.96   92.27
  AISAPS              0.3900    6               76.45             62.56             27.19   93.59

NPV, negative predictive value; PPV, positive predictive value.

Discussion {#s4}
==========

We found that the Chumbler score, A^2^DS^2^ and AISAPS models could reasonably predict pneumonia after IS in the Chinese population. Among them, the A^2^DS^2^ and AISAPS models (whose AUROC was higher than 0.7) had acceptable discriminatory abilities. The discriminatory ability of every risk model was lower in this external validation cohort than in their derivation cohort, which was consistent with the AISAPS study. The AISAPS study developed the AISAPS model to predict pneumonia after IS, as well as compared it with other risk models. They found Chumbler\'s score, A^2^DS^2^ and AISAPS model had acceptable discriminatory abilities in derivation and validation cohort, except Kwon\'s score only had acceptable discriminatory ability in derivation cohort. Chumbler\'s score had acceptable discriminatory ability in the validation cohort, which differed from this study. In addition, the AISAPS study did not report the difference in other risk models except AISAPS.

We found that AISAPS had the highest discriminatory ability, while Chumbler\'s score had the lowest discriminatory ability, which is consistent with the AISAPS study. The AISAPS model may be the most effective one for Chinese patients with IS. Further study is needed to explore the predictive performance of the AISAPS model in other races and regions.

We also analysed the independent risk factors of SAP in our cohort to investigate the reasons why these risks models had different predictive performances in this study. We found that age (OR=1.035, 95% CI 1.021 to 1.049), atrial fibrillation (OR=2.733, 95% CI 1.837 to 4.067), chronic obstructive pulmonary disease history (OR=5.006, 95% CI 2.143 to 11.693), NIHSS score (OR=1.124, 95% CI 1.092 to 1.157), dysphagia (OR=2.908, 95% CI 1.092 to 1.157) and the count of first time white cell count during hospitalisation (OR=1.169, 95% CI 1.116 to 1.224) were independent risk factors for SAP. The independent risk factors in our cohort had the biggest overlap with the items of AISASP, and smallest overlap with Chumbler\'s score. This may explain the differences of predictive performances between these risk models.

In diverse populations, the predictive performances of risk models could be different. So they need to be externally validated before they are used in clinic. As recommended in the guideline about clinical decision rules, the rules at level 1 must be prospectively validated in different populations and have one impact analysis demonstrating change in the clinician\'s behaviour with beneficial consequences, so that rules at level 1 can be used in a wide variety of settings.[@R17]

There are some limitations in this study. First, our study was a retrospective study with potential confounding factors. Second, we only included patients in a single hospital, which could cause selected bias.

For now, whether the clinical application of these risk models can assist in decreasing the incidence of SAP is still uncertain. Prospective studies with a large sample containing different races and a regional population are needed.
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